Completed PHASE1 INTERVENTIONAL 1-arm NCT03026855

Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers

To Demonstrate the Safety and Efficacy of Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers

Sponsor: TotipotentRX Cell Therapy Pvt. Ltd.

Conditions Chronic Ulcer

Interventions Autologous PRP Gel and PRP Injection

Updated 5 times since 2017 Last updated: Jan 17, 2017 Started: Jun 30, 2014 Primary completion: Apr 30, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03026855, this PHASE1 trial focuses on Chronic Ulcer and remains completed. Sponsored by TotipotentRX Cell Therapy Pvt. Ltd., it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

TotipotentRX Cell Therapy Pvt. Ltd.

Data source: TotipotentRX Cell Therapy Pvt. Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Delhi, India